Downregulation of PAK5 inhibits glioma cell migration and invasion potentially through the PAK5-Egr1-MMP2 signaling pathway

Elevated p21-Activated Kinase 2 Activity Results in Anchorage-Independent Growth and Resistance to Anticancer Drug–Induced Cell Death

(2015) Jerry W. Marlin et al.   NEOPLASIA

Inhibition of matrix metalloproteinase-2 by halofuginone is mediated by the Egr1 transcription factor

(2012) Eyal Zcharia et al.   ANTI-CANCER DRUGS

Cyclin D1 G870A Polymorphism is a Risk Factor for Esophageal Cancer Among Asians

(2012) Wenlei Zhuo et al.   CANCER INVESTIGATION

Inverse Correlation of miRNA and Cell Cycle-Associated Genes Suggests Influence of miRNA on Benign Thyroid Nodule Tumorigenesis

(2012) Carolina Ferraz et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Cyclin D1 overexpression supports stable EBV infection in nasopharyngeal epithelial cells

(2012) C. M. Tsang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The role of CCND1 alterations during the progression of cutaneous malignant melanoma

(2012) Laura Vízkeleti et al.   TUMOR BIOLOGY

RUNX3 expression is lost in glioma and its restoration causes drastic suppression of tumor invasion and migration

(2011) Peng-Jin Mei et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

p21-activated kinase 5 inhibits camptothecin-induced apoptosis in colorectal carcinoma cells

(2010) Xia Wang et al.   TUMOR BIOLOGY

P21-activated kinase 5 is overexpressed during colorectal cancer progression and regulates colorectal carcinoma cell adhesion and migration

(2009) Wei Gong et al.   INTERNATIONAL JOURNAL OF CANCER

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

(2009) Roger Stupp et al.   LANCET ONCOLOGY

The role of PAK-1 in activation of MAP kinase cascade and oncogenic transformation by Akt

(2009) P R Somanath et al.   ONCOGENE

P21-activated kinase is required for mitotic progression and regulates Plk1

(2008) B Maroto et al.   ONCOGENE